Drug Development in Dementia

Dementia is a progressive, irreversible decline in cognition that, by definition, impacts on a patient pre-existing level of functioning. The clinical syndrome of dementia has several aetiologias of which Alzheimer’s disease (AD) is the most common. Drug development in AD is based on evolving pathophysiological theory. Disease modifying approaches include the targeting of amyloid processing, aggregation of tau, insulin signaling, neuroinflammation and neurotransmitter dysfunction, with efforts thus far yielding abandoned hopes and ongoing promise. Reflecting its dominance on the pathophysiological stage the amyloid cascade is central to many of the emerging drug therapies.

  • Neurotransmitter based
  • Neuroprotective
  • Anti-inflammatory
  • cognitive enhancers

Related Conference of Drug Development in Dementia

November 20-21, 2017

28th International Conference on Psychiatry & Mental Health

Melbourne, Australia
February 22-23, 2018

10th International Conference on Vascular Dementia

Paris, France
June 18-20, 2018

25th World Congress on Neurology & Neuroscience

Dublin, Ireland

November 5-6, 2018

World Summit on Spine and Spinal Disorders

San Franciso, USA
June 08-09, 2018

World Summit on Stroke & Neurological Disorders

Baltimore, Maryland, USA
June 14-16, 2018

3rd International Conference and Exhibition on Dual Diagnosis

Amsterdam, Netherlands
July 16-17, 2018

25th World Congress on Neurology and Neurodisorders

Melbourne, Australia
August 06-08, 2018

26th European Neurology Congress

Madrid, Spain
August 29-30, 2018

4th World Congress on Parkinsons & Huntington Disease

Zurich, Switzerland
August 29-30, 2018

4th International Conference on Epilepsy & Treatment

Zurich, Switzerland
September 13-14, 2018

7th International Conference on Neurological Disorders & Stroke

Prague, Czech Republic
September 13-14, 2018

4th International Conference on Spine and Spinal Disorders

Prague, Czech Republic
September 17-18, 2018

4th World Congress on Epilepsy and Treatment

Bali, Indonesia

Drug Development in Dementia Conference Speakers

Recommended Sessions

Related Journals

Are you interested in